China's Sirio Healthcare Products Face Automatic Detention, 45 Items Detained as of September 17
Recently, the US Food and Drug Administration (FDA) issued updated import alert measures on its official website, automatically withholding products from a Chinese company. The details are as follows:
| Warning Number |
Release Date |
Region |
Company Name |
Product Name |
Project |
| Feb-45 |
2024/9/17 |
Anhui, Ma'anshan |
Sirio Healthcare (Anhui) Co., Ltd |
Pectin Gummies (2g gummies containing 1mg Melatonin) |
Anthocyanins |
An import alert is a preventive measure taken by the FDA against imported foods that may pose a potential risk when they enter the U.S. market. For those companies or products that trigger import alert conditions, the FDA will perform an automatic Detention Without Physical Examination (DWPE). To be clear, automatic detention does not equate to a determination that an export does not comply with U.S. import regulations. For automatically detained goods, they must be inspected by FDA or its authorized laboratory and reviewed and approved by the local FDA branch before customs will allow them to be released and then sold in the U.S. market.
2026-10-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Indorama Corporation Acquires 100% Stake in Anyang Zhongying Fertilizer
-
“Anti-Overcapacity” Backfires: China’s Chemical Industry Trapped in a Hell of Its Own Making—and Global Pushback
-
Saint-Gobain Expands Its Construction Chemicals Operations in Indonesia
-
China, U.S. and Australia Escalate Antidumping Scrutiny: Chemical Exports Face Rising Compliance Pressure
-
German Chemical Sentiment Hits a Three-Year Low: Supply Disruption Amplifies Pressure on European Manufacturing
-
Asia’s Plastics Chain Faces a Shock: Tight Naphtha Supply Drives Up Polymer Costs
-
EU Chemical Antidumping Complaints Hit a Record High: Trade Remedies Reshape Export Competition
-
New York’s Additive Ban Signals a Tougher Era for Food Formulation
-
Oil-Coal Price Gap Widens! Coal Chemical Enterprises See Significant Profit Surge in H1 2026
-
Domo Chemicals’ German Subsidiary Insolvencies: Energy Costs, Weak Demand and Chinese Nylon Competition
Recommend Reading
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
EU Greenlights Four GM Crops—But Only at the Border
-
Carbon Fiber’s Price Surge Signals a New Era of Strategic Value—and Supply Tension
-
Sherwin-Williams Surpasses $100 Billion in Market Cap: Is This the ‘Apple Moment’ for Paint, or America’s Industrial ‘One Hundred Years of Solitude’?
-
The Carbon Tollbooth Is Open: EU’s CBAM Ushers in a New Era of Climate-Linked Trade
-
Demand Shifts: Butadiene Market Rises First, Then Falls
-
Supply Increase Leads to a Rebound and Subsequent Decline in the Acrylonitrile Market in China
-
Business Society’s Aniline Market Outlook on September 4, 2026: Downward Trend
-
Formic Acid Enters a Consolidation Phase After Reaching a Steady Rise
-
Negative Factors Weighing Down, Palm Oil Prices Weak and Declining